Seeking Economies of Scale for Biocatalysis

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology, APIs, Excipients, and Manufacturing, October 2021
Pages: 12-16

New enzymes and protein engineering have advanced biocatalysis processing toward commercial acceptance. Technology and economic roadblocks must be overcome for the process to be widely embraced by pharma.

SERGEY YAROCHKIN - STOCK.ADOBE.COM

SERGEY YAROCHKIN - STOCK.ADOBE.COM

The advantages that enzymes have as biocatalysts are well known within the pharmaceutical manufacturing industry, not least that they can give excellent specificity and yields, and even facilitate reactions that are difficult with chemical catalysts. Their credentials towards improving sustainability are also increasing the levels of interest for process development, as biocatalytic reactions can be more efficient in terms of solvent and material use.

Read this article in Pharmaceutical Technology’s October 2021 APIs, Excipients, and Manufacturing eBook.

APIs, Excipients, and Manufacturing eBook

Read the article:
Seeking Economies of Scale for Biocatalysis

Read the ebook:
Pharmaceutical Technology APIs, Excipients, and Manufacturing eBook

About the authors

Mark Muldowney is head of technology, and innovation and Greg Holgate is biocatalysis chemist, both with Sterling Pharma Solutions.

Article Details

Pharmaceutical Technology
eBook: APIs, Excipients, and Manufacturing
October 2021
Pages: 12–16

Citation

When referring to this article, please cite it as M. Muldowney and G. Holgate, “Seeking Economies of Scale for Biocatalysis,” Pharmaceutical Technology APIs, Excipients, and Manufacturing eBook (October 2021).

Articles in this issue
Knowledge Management
Pharmaceutical Knowledge Management: Experiences in Drug Development and Manufacturing
Shining a Light on Photochemistry in Flow
Shining a Light on Photochemistry in Flow
Predicting Tablet Potency in Continuous Manufacturing
Predicting Tablet Potency in Continuous Manufacturing
Powder Testing
Building Robust Specifications Using Powder Testing
Global Regulatory Approach to API Manufacturing
Global Regulatory Approach to API Manufacturing
Seeking Economies of Scale for Biocatalysis
Seeking Economies of Scale for Biocatalysis
API Development and Manufacturing: Advantages of Working with Small Molecules
API Development and Manufacturing: Advantages of Working with Small Molecules
Rethinking, Recalibrating, and Retooling
Recent Videos
Behind the Headlines episode 6
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Sanofi Grows Antibody Production in France with €40 Million Investment

Feliza Mirasol
November 22nd 2024
Article

Sanofi will use this investment to increase its antibody bioproduction at its site in Lyon Gerland, France.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Three New European Facilities Established by BioPharmaSpec for R&D

Feliza Mirasol
November 21st 2024
Article

Located in German, Italy, and Lithuania, the new European facilities will specialize in drug discovery and R&D services.

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Jill Murphy
November 14th 2023
Podcast

In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Alentis Therapeutics to Advance Anti-Claudin-1 ADCs to Treat Solid Tumors on $181.4 Million Financing

Feliza Mirasol
November 19th 2024
Article

Financing from OrbiMed, Novo Holdings, Jeito Capital, and others will enable Alentis Therapeutics to advance its pipeline of Claudin-1-targeted ADCs for treating solid tumors.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Frontier Scientific Solutions Plans a Global Free Trade Zone Gateway to Supply Life Sciences Industry on Back of $1.5 Billion Investment

Feliza Mirasol
November 16th 2024
Article

Frontier Scientific Solutions has unveiled plans to use a $1.5 billion commitment from a major investor to create a global free trade zone gateway to facilitate the life sciences supply chain using Wilmington International Airport in North Carolina.